NFATc1 controls the cytotoxicity of CD8<sup>+</sup> T cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28894104.
- Also identified by DOI 10.1038/s41467-017-00612-6 and PMC identifier 5593830.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cytotoxic T lymphocytes are effector CD8<sup>+</sup> T cells that eradicate infected and malignant cells. Here we show that the transcription factor NFATc1 controls the cytotoxicity of mouse cytotoxic T lymphocytes. Activation of Nfatc1 <sup>-/-</sup> cytotoxic T lymphocytes showed a defective cytoskeleton organization and recruitment of cytosolic organelles to immunological synapses. These cells have reduced cytotoxicity against tumor cells, and mice with NFATc1-deficient T cells are defective in controlling Listeria infection. Transcriptome analysis shows diminished RNA levels of numerous genes in Nfatc1 <sup>-/-</sup> CD8<sup>+</sup> T cells, including Tbx21, Gzmb and genes encoding cytokines and chemokines, and genes controlling glycolysis. Nfatc1 <sup>-/-</sup> , but not Nfatc2 <sup>-/-</sup> CD8<sup>+</sup> T cells have an impaired metabolic switch to glycolysis, which can be restored by IL-2. Genome-wide ChIP-seq shows that NFATc1 binds many genes that control cytotoxic T lymphocyte activity. Together these data indicate that NFATc1 is an important regulator of cytotoxic T lymphocyte effector functions.NFAT nuclear translocation has been shown to be required for CD8<sup>+</sup> T cell cytokine production in response to viral infection. Here the authors show NFATc1 controls the cytotoxicity and metabolic switching of activated CD8<sup>+</sup> T cells required for optimal response to bacteria and tumor cells.
Medical subject headings
- Immunological Synapses
- Lymphocyte Activation
- NFATC Transcription Factors
- T-Lymphocytes, Cytotoxic